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ABSTRACT
Moore, Dustin M. M.S.B.M.E., Purdue University, May 2019. Dynamic Control of
Hydrogel Properties via Enzymatic Reactions. Major Professor: Chien-Chi Lin.
Dynamic changes to the extracellular matrix (ECM) impact many cell fate pro-
cesses. The ECM can experience changes in stiffness as well as changes in composi-
tion in response to injury, development, and diseases. To better understand the role
that these dynamic processes have on the cells residing within the environment, re-
searchers have turned towards 4-dimensional (4D) hydrogel designs. These 4D hydro-
gels re-capitulate not only 3-dimensional (3D) matrix architectures, but also temporal
changes in the physicochemical properties. The goal of this thesis was to design a
unify chemistry (i.e., Sortase A (SrtA)-mediated transpeptidation) for dynamic tun-
ing hydrogel stiffness and the presence of bioactive ligands. The first objective was
to establish a tunable and cytocompatible enzymatic scheme for softening cell-laden
hydrogels. Briefly, the effects of SrtA-mediated matrix cleavage were investigated us-
ing poly(ethylene glycol) (PEG)-peptide hydrogels crosslinked by SrtA-sensitive and
insensitive peptides. Initially, the effects of various parameters with respect to cat-
alytic reactions of SrtA were characterized rheologically, including enzyme and sub-
strate concentrations, macromer content, peptide composition, and treatment time.
Gel moduli pre- and post-enzyme treatment were measured to verify SrtA-mediated
hydrogel softening. The cytocompatibility of SrtA-mediated gel softening system was
investigated using human mesenchymal stem cell (hMSC). Upon treatment with SrtA
and an oligoglycine substrate, encapsulated hMSCs exhibited extensive spreading in
comparison to those within statically stiff matrices. The second objective was to es-
tablish a reversible ligand exchange system utilizing SrtA-mediated transpeptidation.
SrtA-sensitive pendant ligands were immobilized within PEG hydrogels, which were
xiv
treated with SrtA and an oligoglycine substrate to afford tunable removal of the pen-
dant ligand. Through measurement of the liberated pendant peptide concentration,
it was found that higher concentrations of SrtA or extending treatment times led
to higher ligand removal efficiency. Finally, the effect of peptide ligand removal on
cell behaviors were evaluated using NIH 3T3 fibroblasts. Fibroblasts were culture
both on and within hydrogels containing SrtA-cleavable cell adhesion peptide. After
treatment, both conditions led to a decrease in fibroblast spreading in comparison
to non-treated gels. Overall, the utility of SrtA as versatile agent for controlling the
mechanical properties and the presence of biologically active components within a
hydrogel system was demonstrated. These systems could be further explored with
natural-based materials to better mimic the physiological environment experienced
by cells.
1CHAPTER 1. INTRODUCTION
1.1 Dynamic Biological Systems and Their Role in Stem Cell Fate
Biological tissues are composed of extracellular matrices (ECM) that undergo
dynamic changes in stiffness, ligand presentation, viscoelasticity, and availability of
soluble signaling molecules. These environmental cues influence morphology, growth,
and differentiation potential of the cells residing in the tissue [1–6]. For example,
mesenchymal stem cells (MSCs) have been shown to change their lineage commitment
when exposed with different matrix stiffness [4, 7] and cell adhesive molecules [8]. In
general, cells can remodel their environments through secretion of proteases such
as matrix-metalloproteinases (MMPs) or matrix proteins (e.g., fibronectin, collagen,
and proteoglycans). Through the secretion of MMPs, cells can degrade and soften the
local matrix. On the other hand, deposition/removal of matrix proteins can induce
changes in intracellular signaling. These dynamic processes can play a significant role
in altering a stem cells fate.
1.1.1 Dynamics of Wound Healing
Wound healing is an example of a natural biological process involving dynamic
changes in local stiffness, growth factors, and ECM composition. There are three
main stages seen in wound healing: inflammation, proliferation, and remodeling.
During the inflammation stage, an increase in cytokines leads to the localization of
inflammatory cells such as macrophages and neutrophils, while platelet aggregation
leads to clotting at the site of the wound. These inflammatory cells scour the region
2and uptake foreign materials and damaged cells to clean out the site. These cells
also secrete growth factors which become immobilized within the ECM. In the pro-
liferation stage, fibroblasts invade the wound site and secrete ECM proteins, much
of which is collagen III rich. This temporary structure is often called the provisional
matrix. The increase of collagen content allows for more fibroblast-ECM interac-
tions through integrin binding and formation of focal adhesion complexes that trigger
mechanotransduction in the cells. Increased matrix stiffness promotes activation of
myofibroblasts, which exert contractile forces within the matrix leading to its in-
creased rigidity. Contraction induced by myofibroblasts also facilitates the release of
various growth factors, such as transforming growth factor-β1 (TGF-β1), that were
otherwise trapped within the ECM [9]. During this stage, the tissue also experiences
hypoxic conditions, which activates angiogenesis to allow for the formation of new
blood vessels within the fibrotic region. The release of cytokines and the increase in
collagen promotes re-epithelization, ultimately leads to proliferation and migration
of epithelial cells to cover the wound. The high collagen content mediates increased
adhesion by epithelial cells, which promotes intracellular mechanotransduction. After
a few days, remodeling begins, in which collagen III deposited by fibroblasts is gradu-
ally degraded and collagen I is secreted to take its place. Other ECM proteins are also
deposited to return the tissue to its natural composition as seen prior being damaged.
The degradation of the provisional matrix coincides with ECM softening [10–13].
Various studies have looked into the roles of MSCs in the three phases of wound
healing [14–16]. Within the inflammation stage, MSCs regulate the inflammatory
response through the secretion of anti-inflammatory cytokines interleukin-10 (IL-10)
and IL-4 [14]. MSCs have also been seen to play a role in managing the immune
response within injured tissue through the secretion of factors such as IL6, TGF-
β, and inerleukin-1 receptor antagonist (IL-1RA), to name a few [15]. Within the
proliferative stage, MSCs have been seen to secrete pro-migratory and proliferative
growth factors such as vascular endothelial growth factor (VEGF), hepatocyte growth
factor (HGF), and platelet derived growth factor (PDGF) [14, 16]. These factors
3promote vascularization as well as infiltration of endothelial cells, fibroblasts, and
keratinocytes. In the remodeling stage, MSC release TGF-β3 as well as keratin growth
factor (KGF) while also regulating MMPs and tissue inhibitor of metalloproteinases
(TIMPS) [14]. Overall, MSCs take on an important role in regulating the wound
healing process.
1.2 Designing Biomimetic Matrices for Culturing Cells
The dimensionality of the matrix in which cells are cultured in has been shown
to have a significant impact on their morphological and signaling properties [7]. In
two-dimensional (2D) culture environments, MSCs spread more as the stiffness of the
substrate increases. In three-dimensional (3D) environments, the opposite was found
to be true, as MSCs adopted a more spherical morphology within stiffer matrices
while spreading in softer matrices [17]. As cells often reside within 3D environments,
researchers have designed various 3D scaffolds to better recapitulate the natural mi-
croenvironments in the ECM. Hydrogels are commonly used due to their high water
content, ability to incorporate biomimetic motifs (for cellular adhesion, degradation,
etc.), and tunability of various mechanical properties. Hydrogels have been created
from a multitude of synthetic (PEG) and natural materials (gelatin, hyaluronic acid,
etc.). Recently, the focus has evolved to designing dynamic hydrogel systems that
can mimic changes in stiffness as well as to allow for the introduction or removal of
bioactive agents [18–20].
1.2.1 Softening Hydrogel Matrix
Recently research has focused on designing hydrogels which mimic the dynamic
changes in stiffnesses seen in natural tissue. Hydrogels can be designed to undergo
temporal degradation through hydrolysis [21,22], photo-lysis [23–25], and proteolysis
[26, 27]. Burdick and colleagues crosslinked methacrylated hyaluronic acid (MeHA)
with dithiothreitol (DTT) and pentaerythritol tetrakis(mercaptoacetate) (PETMA).
4The PETMA structure contains hydrolytically degradable ester motifs. PETMA
containing gels could be gradually softened from an elastic modulus of 17 kPa to
3 kPa over the course of two weeks [21]. Nonetheless, hydrolytic degradation is a
slow process. In this regard, photolabile linkers have been integrated within hydrogel
networks to permit real-time and spatiotemporally controllable degradation. For
example, Anseth and colleagues have designed a hydrogel system crosslinked by PEG-
acrylate containing photolabile nitrobenzyl ether motifs. Introduction of ultraviolet
(UV) light led to the degradation of these linkages. Through the use of a photomask,
the hydrogels could be spatially softened on demand [23]. In another example, Stowers
et al. demonstrated a liposome loaded alginate hydrogel system that could be stiffened
or softened through near infrared light exposure. Briefly, ionically crosslinked alginate
hydrogels were formed with encapsulated liposomes containing gold nanorods and
either calcium chloride or with calcium-chelating diethylenetriaminepentaacetic acid
(DTPA). Upon exposure to 808 nm light, the gold nanorods would radiate heat to
increase the permeability of the liposomes. Calcium chloride released from these
liposomes facilitated further ionic crosslinking of the alginate gels, hence leading to
matrix stiffening. On the other hand, release of DTPA would lead to the chelation of
calcium ions, in turn softening the hydrogels [24].
1.2.2 Reversible Softening of a Hydrogel Matrix
Reversibly softenable hydrogels have also been of interest due to their ability to
mimic the dynamic matrix mechanics observed in normal physiological processes (e.g.,
wound healing). Burdick and colleagues designed hyaluronic acid (HA) hydrogels
crosslinked by thiol-acrylate nucleophilic crosslinking. These HA hydrogels could be
softened owing to the incorporation of photolabile o-Nitrobenzyl linker when exposed
to UV (365nm) light. On the other hand, the methacrylates in the HA hydrogel
network enabled a secondary photopolymerization (400-500nm light) to increase the
network crosslinking density [28].
5Rosales et al. took advantage of azobenzene photoisomerization in conjunction
with azobenzene/β-cyclodextrin guest-host interactions to produce a hydrogel with
reversible softening capability. Uniquely, β-cyclodextrin formed a strong non-covalent
interaction with the trans isomer of azobenzene but not with its cis conformation.
Azobenzene was transitioned from a cis conformation to a trans conformation through
exposure to 365nm and 400-500nm light, respectively. Guest-host gels were formed
using azobenzene-functionalized and β-cyclodextrin-functionalized HA. Softening was
achieved by exposing gels to 365nm light to convert azobenzene to its cis conformation.
Gels were then able to be re-stiffened upon treatment with 420nm light to change
azobenzene back to its trans conformation. Reversible softening and re-stiffening
could be cyclically repeated [25].
1.2.3 Ligand Addition and Removal
To further mimic the dynamic conditions of natural tissue, techniques have been
introduced to permit the exchange of bioactive ligands into and out of hydrogel sys-
tems. Some chemistries have demonstrated the ability to either add or remove specific
ligands into a system on demand, but few have been capable of dynamically adding
and removing ligands repeatedly. One example of the introduction of a ligand on
demand was demonstrated by Cosgrove et al. through the immobilization of integrin-
binding RGD as well as a cadherin binding HAVDI peptide sequences through the
use of photo-initiated thiol-methacrylate Michael-type addition [29]. The addition of
HAVDI regulated MSC contractility, effectively altered cell fate. Other techniques
utilized photochemistries to immobilize ligands post-gelation immobilization of lig-
ands within a network, including thiol-methacrylate reactions [20].
Anseth and colleagues synthesized a photolabile nitrobenzyl ether linker contain-
ing RGD to allow for cleavage of cell adhesion motif via UV light irradiation [23].
Through the use of this technique, they demonstrated that removal of RGD pro-
moted chondrogenic differentiation of hMSCs. Grim et al. investigated the use of
6a reversible thiol-ene chemistry for on-demand and spatially-controllable ligand ex-
change through exposure to light [30]. Allyl sulfide motifs were incorporated within
PEG-dibenzylcyclooctyne (DBCO) PEG-azide gels formed by strain-promoted azide-
alkyne cycloaddition (SPAAC). When exposed with UV (365nm) light and a pho-
toinitiator, lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP), the allyl sulfide
motifs were able to reversibly react with molecules containing free thiol. Grim was
able to spatially immobilize two thiolated proteins within the same matrix. This
was achieved by first incubating and UV treating the gel with thiolated ovalbumin,
and then subsequently incubating with thiolated transferrin and UV treating [30].
Transferrin was replaced within the gels by PEG-thiol upon UV treatment.
1.3 Enzyme-Responsive Hydrogels
Enzymes have often been utilized within hydrogel systems due to their specificity
and cytocompatibility. By incorporating MMP-sensitive motifs within crosslinks,
cells are able to locally degrade the polymer matrix. This allows for cell-mediated
spreading and local softening of the surrounding matrix [31, 32]. By selectively in-
cluding peptide motifs sensitive to specific MMPs, degradation can be cell-type spe-
cific [33,34]. Anseth and colleagues demonstrated the use of cell-mediated cleavage as
a means of controlling available cell adhesion ligand within a hydrogel system. hMSC-
laden PEG thiol-norbornene hydrogels were created with the inclusion of RGD with
or without a linked MMP-sensitive sequence. Cell-secreted MMP led to the cleav-
age of MMP-linked RGD from the gels, which promoted chondrogenic differentiation
of encapsulated hMSCs [35]. Liang et al. were able to soften hepatocarcinoma cell
(HCC)-laden PEG-crosslinked collagen hydrogels from an elastic modulus of 4 kPa to
0.5kPa by introducing soluble MMP-1. HCC cells grown within the MMP-softened
gels formed larger spheroids and were more sensitive to radiation treatment in con-
trast to spheroids grown in non-treated stiff gels [26].
7Chymotrypsin is another cell-secreted protease that has been utilized in hydrogel
softening [36] and ligand removal [37]. Plunkett et al. incorporated a bis-cysteine
containing chymotrypsin-sensitive peptide (CY↓KC) or inert peptide (CSKC) within
thiol-vinyl sulfone crosslinked PEG hydrogels. When treated with -Chymotrypsin,
the hydrogels containing the CYKC sequence degraded while the CSKC crosslinked
hydrogels remained unaffected [36]. The limitations of utilizing protease-sensitive
motifs within hydrogels for user-controlled softening and ligand exchange often arises
from the ability for cells to secrete the same proteases.
Human neutrophil elastase (HNE) is another example of a protease which has
been utilized in the softening of hydrogels. This protease interacts with proteins
and elastin which contain the amino acid sequence Ala-Ala-Pro-Val. Aimetti et al.
demonstrated the use of human neutrophil elastase (HNE) in the controllable degra-
dation of PEG hydrogels containing HNE-sensitive (Ala-Ala-Pro-Val/Nva(norvaline))
crosslinker. Degradation of these hydrogels could be controlled by the concentration
of HNE, crosslinker composition (Valine vs norvaline), and treatment time. They
demonstrated temporally controllable release of bovine serum albumin (BSA) en-
capsulated within the hydrogels by alternating between 30 minute incubations in a
solution with or without HNE [27,38]. They also noted that this degradation occurred
via surface erosion. Ashton et al. incorporated alginase loaded poly(lactic-co-glycolic
acid) (PLGA) microspheres within ionically crosslinked alginate hydrogels. Release
of alginase from the PLGA microspheres, via diffusion, mediated the degradation of
hydrogels. This degradation was also tunable by adjusting alginase concentration
within microspheres and the microsphere concentration within the hydrogels [39].
1.3.1 The Applicability of the Transpeptidase Sortase A
Sortase A (SrtA) is a cysteine transpeptidase that cleaves peptide substrates
with Leu-Pro-X-Thr-Gly (X can be any amino acid except for proline) motif [40–
42]. The high specificity of this enzymatic reaction makes it a cytocompatible op-
8tion for hydrogel modification [43]. SrtA cleaves the sequence between the Thr
and the Gly, forming a thioester intermediate with the Thr and releasing the Gly.
This intermediate reacts with any N-terminal Gly containing substrate, allowing
for the ligation of two desired molecules. As the product of the reaction also con-
tains the Leu-Pro-X-Thr-Gly substrate motif, this reaction is reversible and can be
driven by available secondary substrates containing an N-terminal Gly. In the ab-
sence of a glycine substrate, the intermediate can react with water to produce an
irreversible LPXT-OH product. Wild-type SrtA (SrtAWT) is calcium dependent.
Through genetic engineering, various SrtA mutations have been created to improve
its reactivity independent of calcium. For example, a pentamutant SrtA(SrtA5M)
(P94R/D160N/D165A/K190E/K196T) was designed to increase the catalytic activ-
ity SrtA for up to 140-fold [44]. A SrtA heptamutant (SrtA7M, hereafter referred to as
SrtA) (P94R/E105K/E108A/D160N/D165A/K190E/K196T) was designed through
introduction of two additional mutations (E105K and E108A), which render the hep-
tamutant calcium-independent through the stabilization of the calcium-binding β6-β7
loop [42].
Fig. 1.1: Schematic of the reversible SrtA transpeptidation mechanism.
SrtA has been utilized for many applications including tagging proteins with flu-
orophores [45] and peptide cyclization [46]. For example, Griffith and colleagues uti-
lized SrtA to immobilize epidermal growth factor (EGF, in the form of GGG-EGF)
into PEG hydrogels containing pendant LPRTG [47]. This group also demonstrated
9its use in complete degradation of hydrogels created with a crosslinker containing the
SrtA-sensitive motif [48]. SrtA has also been utilized to crosslink hydrogels [43, 49].
Recently, Arkenberg et al. implemented SrtA-mediated crosslinking mechanism to
form hydrogels that could be subsequently stiffened upon treatment with mushroom
tyrosinase (MT) [50]. Since SrtA can catalyze reversible transpeptidation, Arkenberg
et al. also demonstrated hydrogels containing pendant LPRTG and GGG peptide
could be reversibly stiffened and softened. Specifically, cyclic stiffening and softening
was achieved through incubation in solutions containing either SrtA alone or SrtA
with an oligoglycine substrate [51]. Due to reversibility of the reaction, SrtA is a
very appealing enzyme for introduction and the subsequent removal of substrates on
demand.
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CHAPTER 2. OBJECTIVES
2.1 Overview
Controllable degradation/softening of hydrogels could be achieved through light-
mediated, enzymatic, and hydrolytic reactions. Similarly, techniques have been de-
veloped for removal and addition of specific ligands into a hydrogel system. Many
of these techniques, however, utilize irreversible or non-specific chemistries. SrtA
transpeptidation has been widely utilized in various tagging, immobilization, and con-
jugation methodologies due to its high specificity and orthogonality. The overarching
goal of this thesis was to exploit SrtA for softening and for reversible addition/removal
of bioactive molecules within a hydrogel system.
2.2 Objective 1: Establish an Enzyme-Mediated System for Controlled
Softening of Cell-Laden Hydrogels
The first objective of this thesis was to utilize SrtA-mediated transpeptidation
for on-demand softening of cell-laden hydrogels. To achieve this, PEG-based hydro-
gels were formed with SrtA-sensitive and insensitive peptide crosslinkers. The gels
were crosslinked via photo-click thiol-norbornene chemistry. The softening efficiency
of various SrtA and oligoglycine substrate concentrations was investigated. The ini-
tial macromer concentration and the ratio of SrtA-sensitive and insensitive peptide
sequences within hydrogels was investigated to characterize controllable degrees of
softening. The system was then utilized to observe the effects of matrix softening on
spreading of encapsulated hMSCs.
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2.3 Objective 2: Establish an Enzyme-Mediated System for On-Demand
Ligand Exchange
The second objective of this thesis was to utilize the same SrtA-mediated transpep-
tidation to introduce and/or remove cell-adhesive ligands on demand. Due to the re-
versible nature of SrtA transpeptidation, this would theoretically allow for repeated
ligand exchange. To accomplish this, PEG-based hydrogels were created with an
included SrtA-sensitive pendant ligand. The pendant could be removed upon treat-
ment with SrtA and an oligoglycine substrate. The cleaved pendant was then able
to be quantified. The effects of SrtA concentration and treatment times on ligand
exchange were investigated. To further analyze SrtA-mediated ligand exchange, 3T3
fibroblasts cultured on gels with SrtA-sensitive cell adhesion peptide were treated to
remove the bioactive molecule.
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CHAPTER 3. MATERIALS AND METHODS
3.1 Materials
Eight-arm PEG-OH (PEG8OH, 20kDa) and four-arm PEG-SH (PEG4SH, 10kDa)
were acquired from JenKem Technology. 5-Norbornene-2-carboxylic acid, 2-butanone,
N ,N -dicyclohexylcarbodiimide (DCC), 4-(dimethylamino)pyridine, lithium bromide,
(DMAP), dimethyl phenylphosphonite, tyrosinase, 2,4,6-trimethylbenzoyl chloride,
diethyl ether, and isopropyl-D-1 thiogalactopyranoside (IPTG) were obtained from
Sigma-Aldrich. Fmoc-protected amino acids, hydroxybenzotriazole (HOBt), and
N ,N ,N ,N -tetramethyl-O-(1H-benzotriazol-1-yl)uranium hexafluorphosphate (HBTU)
were purchased from Anaspec. 3-Methyl-2 benzothiazolinone hydrazone hydrochlo-
ride monohydrate (MBTH) was purchased from Acros Organics. Tyramine hydrochlo-
ride was purchased from Chem-Impex International. Glycinamide hydrochloride was
obtained from Alfa Aesar. BL21 Escherichia coli (E. coli) was purchased from New
England Biolabs. Kanamycin sulfate was obtained from IBI Scientific. Lysogeny
broth (LB), Lennox formulation, agar and broth were obtained from DOT Scientific.
Mammalian cell Live/Dead staining kit was obtained from Life Technologies Corp.
All other chemicals were obtained from Fisher Scientific unless otherwise noted.
3.2 PEG Macromers, Peptide, and LAP Synthesis
Eight-arm PEG-norbornene (PEG8NB) was synthesized as reported with minor
modifications to the protocol [52]. 5-norbornene-2-carboxylic acid (5X molar excess to
PEG hydroxyl groups) was reacted with DCC (2.5X) in anhydrous DCM for 1 hour to
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form norbornene anhydride with a by-product of urea. Urea was filtered out and the
remaining norbornene anhydride was added dropwise via an addition funnel to a two-
necked round-bottom flask containing PEG8OH, DMAP (0.5X), and pyridine (0.5X)
under nitrogen. The reaction occurred overnight at dark. The process was repeated
by reacting freshly synthesized norbornene anhydride with the PEG8NB product
overnight to further increase norbornene functionalization. The PEG8NB product
was recovered via precipitation in cold diethyl ether and vacuum dried overnight.
The dried product was redissolved in double distilled H2O (ddH2O) and dialyzed
against ddH2O for 3 days at room temperature (MWCO: 6000-8000 kDa), and then
lyophilized. 1H NMR (Bruker Advance 500) was used to determine the degree of
functionalization (∼85-95%)
Peptides (KCLPRTGCK, KCLPRTACK, GGGGC, KCGPQGIWGQCK,
CRGDS, CLPRTGYK, CLPRTGRGDS, and GGGRGDS) were synthesized via Fmoc
coupling chemistry in an automated, microwave-assisted peptide synthesizer (Liberty
1, CEM). Crude products were cleaved from the resin with 95% trifluoroacetic acid
(TFA), 2.5% ddH2O, 2.5% triisopropylsilane (TIS), and 5% (w/v) phenol at room
temperature with stirring for 3 hours. Cleaved peptides were precipitated in cold
ethyl ether and vacuum dried overnight. The dried peptide was purified via HPLC
(Flexar system, Perkin Elmer) and confirmed via mass spectrometry (QTOF, Agi-
lent Technologies). Peptides were aliquoted in pH 7.4 PBS and stock concentrations
measured via the use of Ellmans assay (PIERCE) to quantify free sulfhydryl groups.
GGGRGDS was aliquoted directly by molecular weight into 120mM stock solutions.
Photoinitiator lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) was syn-
thesized as previously described [53].
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3.3 Heptamutant SrtA Expression and Purification
Heptamutant SrtA (P94R, E105K, E108Q, D160N, D165A, K190E, K196T) was
expressed and purified as described previously [50,54]. Briefly, pet30b-7M SrtA plas-
mid (gift from Hidde Ploegh. Addgene plasmid #51141) was transformed into compe-
tent BL21 E. coli and grew on an LB-agar plate added with kanamycin (30µg/mL).
Bacteria colonies were picked inoculated in 10mL of LB broth in the presence of
kanamycin (30µg/mL). After overnight shaking (37°C, 220 rpm), the cultures were
diluted 100-fold in kanamycin-LB media and shaken at 37°C until the optical density
at 600 nm (OD 600) reached 0.4-0.6. SrtA expression was then induced via the addi-
tion of IPTG (400µM) and flasks were shaken for 3 hours at 37°C. After induction,
cells were pelleted via centrifugation at 8000rpm for 15 minutes. Pellets were stored
at 80°C until lysis was performed. Cells were lysed via a 30-minute incubation at 4°C
while suspended in a lysis buffer (20mM Tris, 50mM NaCl, 0.2mg/mL lysozyme, 1X
Halt EDTA-free protease inhibitor cocktail, and DNase I). The lysed cell solution was
sonicated for 2 cycles lasting 3 minutes with a 30% duty cycle, at 20% amplitude,
and with a 3-minute cool-down period between cycles. The lysate was centrifuged at
10,000×g and 4°C for 20 minutes and the supernatant was recovered for further pu-
rification. SrtA was purified through the use of His60 Ni Superflow resin and columns
per the manufacturers protocol. Purified SrtA was concentrated with Ultra-15 Cen-
trifugal Filter Units (3kDa MWCO, Amicon) and desalted with Zeba Spin desalting
columns (7kDa MWCO, Thermo Fisher Scientific). The enzyme was aliquoted in
pH 7.4 PBS and stored at 80°C until use. The concentration of aliquoted SrtA was
measured via an Ellmans assay to detect the single, free sulfhydryl of SrtA.
3.4 Hydrogel Photopolymerization for Characterizing Softening
For experiments related to characterizing SrtA-mediated softening, hydrogels were
fabricated by reacting PEG8NB with bis-cysteine containing peptides (e.g., KC-
LPRTG-CK, KC-LPRTA-CK) via thiol-norbornene photo-click chemistry. PEG8NB
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and peptides were mixed at a stochiometric ratio of thiol to norbornene (thiol / nor-
bornene = R) with photoinitiator LAP (1mM). The precursor solution was injected
between two glass slides separated by 1mm Teflon spacers, and exposed to 365nm
light (5mW/cm2) for 2 minutes. Hydrogels were swollen in a pH 7.4 PBS solution
overnight prior to softening experiments.
3.5 Hydrogel Photopolymerization for Characterizing Ligand Exchange
For experiments related to the characterization of SrtA-mediated ligand exchange,
hydrogels were fabricated by reacting PEG8NB with DTT or PEG4SH crosslinker and
cysteine-containing peptides (C-LPRTGRGDS or C-LPRTGYK) via thiol-norbornene
photo-click chemistry for stiffness or ligand exchange quantification, respectively.
PEG8NB, crosslinker, and peptides were mixed at a stochiometric ratio of thiol to
norbornene with photoinitiator LAP (1mM). The precursor solution was injected
between two glass slides separated by 1mm Teflon spacers, and exposed to 365nm
light (5mW/cm2) for 2 minutes. Hydrogels for characterizing changes in stiffness via
ligand exchange (PEG8NB-DTT-CLPRTGRGDS) were swollen in a pH 7.4 PBS so-
lution within a 48-well plate overnight prior to ligand exchange. Hydrogels used for
quantifying ligand exchange (PEG8NB-PEG4SH-CLPRTGYK) were swollen in sep-
arate 1.5mL microcentrifuge tubes containing 500µL pH 7.4 PBS solutions overnight
prior to ligand exchange.
3.6 Sortase A-Mediated Hydrogel Softening
Softening of PEG-peptide hydrogels was achieved via the incubation of swollen
hydrogels in a solution containing specified concentrations of SrtA and oligoglycine
substrate (GGGGC, glycinamide, etc.). Storage moduli of the gels were measured
before, at specified time points during, and after softening using oscillatory rheom-
etry in strain sweep mode (8mm parallel plate geometry, 0.1% to 5% strain at 1Hz
frequency, 750µM gap size).
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3.7 Estimation of SrtA Diffusivity Within Softening Hydrogels
To determine the diffusivity of SrtA within a softening hydrogel, the mesh size
of 4% weight PEG-KCLPRTACK hydrogels was measured at varied R ratios (R=1,
0.8, 0.6, and 0.4). Two sets of gels were formed as described above for each R ratio.
The storage moduli of the first set of gels were obtained via oscillatory rheometry in
strain sweep mode (8mm parallel plate geometry, 0.1% to 5% strain at 1Hz frequency)
after an overnight swelling period. The second set of gels were immediately placed
in a desiccator overnight, and the initial dry weight was measured the next day on
a scale (WDry,1). The dry gels were then placed in ddH2O to swell overnight. The
swollen mass was then measured via a scale (WSwollen) and placed into a desiccator
overnight to dry again. The final dry weight of the gels was then measured via a
scale (WDry,2). The mass swelling ratio (Qm) is calculated as Qm=
WSwollen
WDry,2
. Using the
mass swelling ratio and the densities of the polymer (ρ2=1.087g/mL for PEG) and of
the solvent (ρ1=1.00g/mL for water), the volumetric swelling ratio (Qv) and polymer
volume fraction (ν2) could be calculated as:
Qv = 1 +
ρ2
ρ1
(Qm − 1) = 1
ν2
(3.1)
We can calculate the average molecular weight between crosslinks via the use of the
equation below. In this equation, ν is the specific volume of the polymer (ν= 1
ρ2
=0.92
ml/g for PEG), ν1 is the molar volume of the solvent (18cm
3/mol for water), X1,2
is the polymer-water interaction coefficient (0.45 for PEG), and Mn represents the
molecular weight of the polymer (20000g/mol for the PEG used).
1
M c
=
2
Mn
−
ν
ν1
(ln(1− ν2) + ν2 +X1,2ν22)
ν
1
3
2 − ν22
(3.2)
The root-mean-squared end-to-end distance between two crosslinks ((r20)
1
2 ) can
be calculated as the following, in which l is the average bond length of the polymer
backbone, Cn is the Flory characteristic ratio (6.9 for PEG), n is the number of bonds
17
within the repeat unit of the polymer (3 for PEG), and Mr is the molecular weight
for the polymer repeat unit (44g/mol for PEG):
(r20)
1
2 = l(Cn
nM c
Mr
)
1
2 (3.3)
Finally, the mesh size can be calculated using the following equation:
ξ = ν
− 1
3
2 (r
2
0)
1
2 (3.4)
The diffusivity of SrtA in the hydrogel was then predicted via the use of a model
adapted by Lustig and Peppas [55]:
D
D0
= e−
γ
Qv−1 (1− rs
ξ
) (3.5)
In which γ, the ratio of critical volume required for movement of diffusant over the
average free volume per solvent molecule, is assumed 1, and rs is the hydrodynamic
radius of the SrtA heptamutant. To estimate the hydrodynamic radius of heptamu-
tant SrtA, the protein structure was predicted via the use of I-TASSER suite [56].
The hydrodynamic radius and diffusivity were obtained via the use of HydroPRO
(rs=1.592nm, D0=1.01×10−10 m2/sec).
3.8 Sortase A-Mediated Ligand Exchange and Characterization
Ligand exchange in PEG8NB-KCLPRTACK-CLPRTGRGDS hydrogels was ach-
ieved by incubating the swollen gels in a buffered solution containing 25µM SrtA
and 12mM GGGGC for 4-hours. Gels were subsequently washed overnight with PBS
prior to measurement. The storage moduli of the gels were measured before and
after treatment using oscillatory rheometry in strain sweep mode (8mm parallel plate
geometry, 0.1% to 5% strain at 1Hz frequency). Gels were treated with Ellmans
reagent to qualitatively confirm GGGGC immobilization.
Quantification of ligand exchange in PEGNB-PEGSH-CLPRTGYK hydrogels was
achieved by incubating swollen gels in a 500µL buffered solution containing specified
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concentrations of SrtA and 24mM glycinamide for specified treatment times within
1.5mL microcentrifuge tubes. The PBS solutions used for swelling were collected and
saved for determining immobilization efficiency. Treatment solutions were collected
for release quantification after the specified treatment times. Quantification of im-
mobilization efficiency was achieved via use of MBTH and Tyrosinase to determine
free CLPRTGYK which was not immobilized within the PEGNB network. Release
was quantified via the use of MBTH and Tyrosinase to determine the concentra-
tion of cleaved GYK within the treatment solution and normalized with respect to
immobilized CLPRTGYK determined with respect to each gel.
In brief, a 5mM stock solution of MBTH was prepared in pH 6.0 PBS, a 1kU/mL
Tyrosinase stock solution was prepared in pH 7.4 PBS, and a 1mM tyramine solution
was prepared in pH 7.4 PBS. Six serial 2-fold dilutions of the tyramine standards were
created with a PBS blank. 20µL of each standard and unknown (PBS wash solutions
and release treatment solutions) was added to a 96-well plate (in triplicate). 40µL of
the 5mM MBTH solution was added to each well, followed by 100µL of pH 7.4 PBS,
and then 40µL of 1kU/mL Tyrosinase. The solutions were allowed to react for 30
minutes at room temperature while covered. The absorbance at 460nm of each well
was measured, and the concentration of tyrosine within each swelling and treatment
solution was calculated based on the tyramine standard.
3.9 Cell Culture
Human mesenchymal stem cells were maintained in low glucose Dulbeccos Mod-
ified Eagles Medium (DMEM) supplemented with 10% fetal bovine serum (FBS),
1ng/mL basic fibroblast growth factor (bFGF), and 1X penicillin streptomycin. bFGF
was supplemented in the media at 1ng/mL as this concentration has been shown to
maintain viability and proliferation of hMSCs during in vitro culture [57]. Media was
refreshed every 23 days.
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Fibroblast (NIH 3T3) cells were maintained in high glucose Dulbeccos Modified
Eagles Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1X
penicillin streptomycin. Media was refreshed every 23days.
3.10 hMSC Encapsulation
Prior to encapsulation, hMSCs were trypsinized, counted via a hemocytometer,
and resuspended in Dulbeccos phosphate buffered saline (DPBS). Resuspended cells
were introduced into a pre-mixed precursor solution (5×106 cells/mL) containing
3.5% PEG8NB, 1mM CRGDS, 50% KCGPQGIWGQCK (MMP), and 50% KCL-
PRT(A/G)CK (inert/softenable, respectively) (R=1). Precursors were sterile-filtered
prior to addition. Photoinitiator LAP was added at 1mM and the solution mixed.
The cell-precursor solutions were pipetted into modified 1mL syringe molds and ex-
posed to UV-light (365nm, 5mW/cm2) for 2 minutes. Gels were transferred to a
24-well plate containing fresh media.
3.11 Softening of hMSC-Laden Hydrogels
Following encapsulation, hMSC-laden hydrogels were cultured in media for 7 days
prior to SrtA-induced softening. Media was refreshed every 23 days. Softening was
achieved through incubation of hydrogels with media containing 25µM SrtA and
12mM glycinamide for 4 hours on day 7 post-encapsulation. Gels were subsequently
washed with fresh media for 4 hours to remove remaining SrtA and glycinamide and
media refreshed. Media was refreshed every 2-3 days. Live/dead staining and confo-
cal microscopy imaging (Olympus Fluoview FV100 laser scanning microscope) were
performed on days 1, 7, and 14 post-encapsulation to assess cell viability and morphol-
ogy. At least three z-stacked images per gel (10 slices, 100µm overall thickness) were
taken. F-actin and DAPI stain imaging were performed on day 14 post-encapsulation
for assessing cytoskeletal structure and cell morphology. Circularity and average cell
area values were measured using ImageJ software from the F-actin/DAPI stained
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confocal images Circularity and average cell area values were measured using ImageJ
software from the F-actin/DAPI stained confocal images. Circularity is quantified
as 4pi Area
Perimeter2
and the area was quantified using the Analyze Particles function in
ImageJ.
3.12 Removal of Pendant Cell-Adhesion Peptide in 2D Fibroblast
Culture
1 day prior to 3T3 fibroblasts cell seeding, 4% wt PEG8NB-1mM CLPRTGRGDS-
PEG4SH gels were formed within a 15-well angiogenesis plate (15-µslide IbiTreat,
IBIDI). Precursor solutions were sterile filtered prior to usage. Precursors were mixed
with 1mM LAP, injected into wells, and subjected to UV-light (365nm, 5mW/cm2)
for 2 minutes. Wells were filled with 50µL of media to allow for hydrogel swelling
overnight. After swelling and prior to cell seeding, the fibroblast cells were trypsinized,
counted (Countess© II Automated Cell Counter, ThermoFisher), and resuspended in
media at 106 cells/mL. Swelling media was removed from the angiogenesis plate and
replaced with 50µL of the cell suspension per well (5×104 cells/well seeding). Cells
were given one day to grow prior to treatment. The next day, the media was re-
moved and replaced with corresponding treatment media (conditions: normal media,
6mM glycinamide only, 25µM SrtA only, and 25µM SrtA with 6mM glycinamide).
Cells were continuously imaged via 4X brightfield montage and z-stack images (Lion-
heart FX automated microscope, BioTek) for 48 hours with 2-hour imaging intervals.
Treatment media was refreshed every 24 hours. Images were analyzed in ImageJ for
morphological quantification of cell cluster area and aspect ratio.
3.13 Fibroblast Encapsulation
Prior to encapsulation, 3T3 fibroblasts were trypsinized, counted (Countess© II
Automated Cell Counter, ThermoFisher), and resuspended in DPBS. Resuspended
cells were introduced into a pre-mixed precursor solution (5×106 cells/mL) containing
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2% wt PEG8NB, 1mM CLPRTGRGDS, and KCGPQGIWGQCK (R=1). Precursors
were sterile-filtered prior to addition. Photoinitiator LAP was added at 1mM and the
solution mixed. The cell-precursor solutions were pipetted into modified 1mL syringe
molds and exposed to UV-light (365nm, 5mW/cm2) for 2 minutes. Gels were then
transferred to a 24-well plate containing fresh media.
3.14 Removal of Pendant Cell-Adhesion Peptide in 3D Fibroblast
Culture
After encapsulation, treatment gels were incubated in media containing 25µM
SrtA and 6mM glycinamide for 24 hours. Non-treated gels were incubated in fresh
media. The treatment media was replaced with fresh media for 4 hours to wash the
gels, and subsequently cultured within fresh media for the remainder of the study.
Media was refreshed every 2-3 days. Live/dead staining and confocal microscopy
imaging (Olympus Fluoview FV100 laser scanning microscope) were performed on
days 1, 7, and 14 post-encapsulation to assess cell viability and morphology. At least
three z-stacked images per gel (10 slices, 100µm overall thickness) were taken. F-actin
and DAPI stain imaging were performed on day 14 post-encapsulation for assessing
cytoskeletal structure and cell morphology.
3.15 Statistical Analysis
A two-way analysis of variance (ANOVA) was performed with Tukeys multiple
comparison test to evaluate significance of softening of gels with varied PEG macromer
concentration and “A” and “G” content. For hMSC area and circularity analysis,
two-tailed t-tests were performed with Welchs correction for differences in sample
sizes. For the analysis of GYK ligand removal, a one-way ANOVA was performed
with Tukeys multiple comparison test. Single, double, triple, and quadruple asterisks
represent p<0.05, 0.01, 0.001, 0.0001, respectively. All experiments were completed
independently three times. Quantitative results are presented as mean ± SEM.
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CHAPTER 4. RESULTS AND DISCUSSION
4.1 The Role of Material Selection in 3D Cell Culture
Throughout this work, hydrogel formation was performed through the use of the
cytocompatible photo-click thiol-norbornene chemistry. A basic schematic of the
chemistry is shown in Figure 4.1 below. This chemistry has been previously shown
to be cytocompatible for the formation of cell-laden hydrogels [58,59].
Fig. 4.1: A schematic of the photo-click thiol-norbornene light-initiated chemistry.
The selection of specific materials for use in 3D and 4D cell culture can have a sig-
nificant impact on cell fate processes. For example, preliminary studies of this thesis
project were focused on using synthetic or natural materials for encapsulation of hu-
man induced pluripotent stem cell (hiPSC). Synthetic hydrogels were crosslinked from
8-arm PEGNB macromer and protease-sensitive bis-cysteine crosslinker (KCGPQG ↓
IWGQCK), as well as pendant cell adhesion peptide (CRGDS). On the other hand,
natural material-based hydrogels were prepared using gelatin-norbornene (GelNB),
which was crosslinked with PEG4SH. Dispersed hiPSCs were encapsulated in either
natural or synthetic-based hydrogels and cultured for 4 days. While hiPSCs formed
spheroids in both PEG- and gelatin-based hydrogels, cell clusters in PEG-based hy-
drogels were more irregular than those in the gelatin-based hydrogels (Figure 4.2).
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The irregular cell cluster morphology observed in the PEG-based hydrogels were po-
tentially a result of cell-mediated attachment and remodeling/cleavage of the matrix.
On the other hand, the complex composition of gelatin within the natural-based
hydrogels likely contains other motifs that affected the morphogenesis of the encap-
sulated hiPSCs. Future studies are required to elucidate the underlying mechanism
leading to confined spreading of hiPSCs in gelatin-based hydrogels. Nonetheless,
this preliminary study has demonstrated the cytocompatibility of thiol-norbornene
hydrogels for stem cell encapsulation.
Fig. 4.2: Representative z-stack images (20 slices - 5µm each - 100µm total) of live
and dead stained hiPSC (P3, 5×106 cells/mL) imaged on days 1 and 4
post-encapsulation (scale bar=200µm). hiPSCs were encapsulated within either 2%
wt GelNB-2%PEG4SH(GelNB) or 2.5% wt PEG8NB-4.5mM
KCGPQG↓WGQCK-1mM CRGDS (PEG8NB) hydrogels. Gels were maintained in
Essential 8 media with Essential 8 media supplement and 10µM ROCK inhibitor
(Y-27632). (Unpublished Data).
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4.2 SrtA Heptamutant Diffusivity Within Hydrogels of Varied Stiffness
Heptamutant SrtA was utilized throughout this work due to its mutations that
afford an increased and calcium-independent reactivity [42]. Since SrtA needs to
infiltrate in hydrogel to achieve softening, its diffusion in a highly swollen hydrogel was
first approximated. The structure of SrtA was predicted via the I-TASSER suite [56]
and is shown in Figure 4.3. This structure was introduced into HydroPRO to estimate
the hydrodynamic radius and diffusivity of SrtA. The calculated hydrodynamic radius
was estimated as 1.592nm and the corresponding diffusivity of SrtA in water was
estimated to be 1.01×10−10 m2/sec. Next, hydrogels were crosslinked with different
thiol:norbornene ratio (R), which yielded different shear moduli (G). The moduli
data were correlated with corresponding mesh size (calculated from hydrogel swelling
ratios Figure 4.4a). This range of mesh sizes was then used to estimate the diffusivity
of SrtA within these hydrogels according to the Lustig-Peppas approximation (Figure
4.4b) [55].
Fig. 4.3: Predicted structure of SrtA obtained via the use of I-TASSER suite.
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Fig. 4.4: (a) Mesh size measurements of hydrogels at varied stiffnesses. (4% wt
PEG8NB-KCLPRTACK, R=1,0.8,0.6,0.4) (b) Estimated SrtA diffusivity within
hydrogels at varied stiffnesses.
Based the relatively small difference in the estimated enzyme diffusivity (e.g., 0.84
to 0.90 ×10−10 m2/s) in gels of varying stiffnesses, we reasoned that the process of
softening would not drastically affect the diffusivity of SrtA within the hydrogel net-
work. As the gels become softer, the enzyme would diffuse more readily through the
matrix. It is important to note that the diffusion of SrtA would, however, be affected
by binding with immobilized substrate (e.g., LPRTG) in the hydrogel network, which
is not included in the estimation of SrtA diffusivity above.
4.3 Concept of SrtA-Mediated Softening of PEG-Peptide Hydrogels
SrtA has been widely used for a variety of bioconjugation applications, includ-
ing protein tagging [45], peptide cyclization [46], and protein immobilization [60].
Recently, SrtA has been utilized in the formation of hydrogels and has allowed for
reversibly stiffening and softening hydrogel networks cyclically [43, 50, 51]. We en-
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visioned the utilization of SrtA as a means to provide precise control over hydrogel
softening. This was achieved through forming hydrogels with the Leu-Pro- Arg-Thr-
Gly SrtA linker. A peptide sequence not sensitive to SrtA (i.e. LPRTA) was used
to provide tunable hydrogel softening. Hydrogels could be initially formed by a va-
riety of crosslinking methods, given they do not interfere with sequence integrity.
Formation of hydrogels within this work was achieve through cytocompatible and
bio-orthogonal thiol-norbornene photo-click reaction of PEG8NB with bis-cysteine
containing SrtA-sensitive (KCLPRTGCK, “G”) or SrtA-insensitive (KCLPRTACK,
“A”) peptide. Flanking lysine residues were included to improve their solubility.
Upon incubation of these hydrogels within a solution containing SrtA and an oli-
goglycine substrate, SrtA-sensitive linkages (G) undergo transpeptidation leading to
softening, while SrtA-insensitive linkages (A) would remain intact as illustrated in
Figure 4.5.
Fig. 4.5: Schematic of the on-demand SrtA-mediated softening system. Hydrogels
are formed via photo-click thiol-norbornene chemistry and SrtA-sensitive crosslinks
(KCLPRTGCK) are cleavable via the introduction of SrtA and an oligoglycine
substrate (Gn). Inert crosslinks (KCLPRTACK) remain unaffected by the
introduction of SrtA and Gn.
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4.3.1 Characterizing SrtA-Mediated Softening
Utilizing the hydrogel network structure shown in Figure 4.5 (3 wt% PEG8NB,
A:G ratio=50%:50%, and R=1, G0∼2100 Pa), we first sought to investigate the ef-
ficiency of SrtA-mediated softening at specific SrtA concentrations (Figure 4.6a).
At lower concentration of SrtA (e.g., 10µM), the moduli of hydrogels decreased much
slower than that with higher SrtA concentrations. Furthermore, a SrtA concentration
of 25 or 50 µM yielded similar softening profiles, suggesting that the transpeptidation
reaction occurred in the hydrogel was rapid and diffusion-limited.
The concentration of oligoglycine substrate was subsequently investigated. As
shown in Figure 4.5b, a higher degree of softening was observed at increasing concen-
tration of GGGGC (with 25µM SrtA, Figure 4.6b). This experiment was repeated
with the use of glycinamide in place of GGGGC and a similar trend was observed
(data not shown). In the absence of an oligoglycine substrate, the SrtA reaction un-
dergoes a much slower irreversible hydrolysis reaction, which converts LPRTG into
LPRT-OH with the release of the glycine [40]. This hydrolysis reaction is always in
competition with the natural transpeptidation reaction, but as seen in the figure it
is noticeable slower (25% softening after 24 hours). When limiting the available time
for transpeptidation to occur, by transferring the hydrogel to fresh media which does
not contain SrtA or oligoglycine substrate, we were able to stop the softening process
from completing (Figure 4.6c). The final moduli of these gels (at ∼0.5, 2.5, and 4
hours) were constant at around the same level as when they were first transferred to
enzyme-free solutions.
We also investigated the use of different oligoglycine substrates for softening our
hydrogel network (12mM Glycinamide vs 12mM GGGGC) and saw little difference
in degree of softening achieved (3% PEG, A:G ratio=50%:50%, R=1, 25µM SrtA)
(Figure 4.6d). This result demonstrated the applicability of different oligoglycine
substrates for producing similar softening effects.
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Fig. 4.6: Characterization of various parameters in the SrtA-mediated softening
system (3% wt PEG8NB, R=1, 50% A: 50% G) on hydrogel moduli measured via
shear-rheology at various time points before, during, and after treatment. (a) The
effect of SrtA concentration on the stiffness of gels also incubated with 12mM
GGGGC. (b) The effect of GGGGC concentration on the stiffness of gels also
incubated with 25µM SrtA. (c) The effects of treatment time on the stiffness of gels
treated with 25µM SrtA and 12mM GGGGC (0.5, 2.5, and 4.0 hour treatment). (d)
Utilization of different oligoglycine (Glycinamide and GGGGC) substrates in the
softening of hydrogels. (n=3).
29
In an attempt to explore the reversibility of network softening, a new peptide
sequence (i.e., KCLPRTGGGCK) was used to crosslink hydrogel. This peptide was
used because after SrtA-mediated transpeptidation the linker was cleaved into KCL-
PRTG and GGGCK motifs, which were both still linked to the hydrogel network.
Ideally, these two pendant peptides could be ligated by additional SrtA, leading to
hydrogel stiffening. Experimentally, reversible hydrogel softening/stiffening was ex-
plored using gels formed from PEG8NB with 50% DTT crosslinker and 50% KCL-
PRTGGGCK peptide linker. Control gels not sensitive to SrtA treatment were cre-
ated with PEG8NB and 100% DTT crosslinker. Initial softening was performed
through treatment with 25µM SrtA and 12mM glycinamide. Gels were washed of
unreacted glycinamide and subsequently incubated with 25µM SrtA for 4 hours to
initiate re-stiffening. Unfortunately, limited re-stiffening was achieved (Figure 4.7).
This may be because the cleaved pendant GGG peptide became inaccessible to the
LPRT-SrtA complex. As the linkages are cleaved, the gels swell more leading to an
increase in the distance between pendant LPRTG and pendant GGG.
Fig. 4.7: Attempted re-stiffening of SrtA-sensitive hydrogels. Hydrogels were formed
with PEG8NB and either 100% DTT or 50% KCLPRTGGGCK with 50% DTT.
Gels were swollen overnight prior to treatment for 4 hours with 25µM SrtA and
12mM glycinamide. Gels were subsequently washed and treated for 4 hours with
25µM SrtA.
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4.3.2 Tuning SrtA-Mediated Softening via Hydrogel Composition
By adjusting the initial PEG8NB macromer concentration we were able to pro-
duce gels with varied initial moduli, each of which is significantly softened when
treated with SrtA and an oligoglycine substrate (A:G ratio=50%:50%, R=1, 25µM
SrtA, 12mM GGGGC. Figure 4.8a). To account for increasing SrtA-sensitive ligand
concentration, it may be necessary to adjust treatment time as the overall ligand
concentration would vary at similar A:G ratios.
The final moduli of the fully softened hydrogels with the same PEG8NB macromer
content (3 wt%) were easily tuned by adjusting the ratio of A and G (Figure 4.8b). In
addition, by adjusting concentrations of PEG8NB macromer and the A:G ratio, we
were able to form gels with different initial moduli but were softened to the same final
moduli after 4 hours of SrtA treatment. Even further we were able to create gels with
similar initial moduli but were softened to different final moduli after SrtA treatment
(25µM SrtA and 12mM GGGGC. Figure 4.8c). Together, these results demonstrated
that the hydrogels can be controllably tuned to specific moduli by adjusting macromer
compositions or by adjusting the enzyme treatment conditions.
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Fig. 4.8: Controlling the initial and final moduli of SrtA-softenable hydrogels via
PEG macromer concentration and degradable composition (treated with 25µM SrtA
and 12mM GGGGC). (a) Initial and final hydrogel moduli tuned via PEG8NB
macromer concentration (50% A:50% G, R=1). (b) Tunable softening of 3% wt
PEG8NB hydrogels with varied A and G compositions. The remainder of the gel
crosslinks were A linkages (i.e. 50% G and 50% A). (c) Softening of tuned hydrogels
via PEG macromer concentration and A:G composition to similar levels after a
4-hour treatment period. (n=3).
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4.3.3 Effect of SrtA-Mediated Softening on hMSC Morphology
The SrtA-mediated softening hydrogel was used as a means to study the effects of
temporally softening the matrix on morphology of hMSCs. Hydrogels have been used
extensively for 3D culture of hMSCs. Studies have reported that hMSCs respond
to varying stiffnesses by elongating in softer environments and remaining spherical
in stiffer environments [4, 7]. To investigate the effects of SrtA-mediated soften-
ing on hMSCs, we encapsulated cells within PEGNB hydrogels of which 50% of
crosslinks contained either SrtA-sensitive G or insensitive A peptide crosslinker, while
the remaining 50% of crosslinks were composed of MMP-degradable crosslinker (e.g.,
KCGPQG↓IWGQCK). The inclusion of MMP-sensitive peptide allows for cells to
remodel their local environment through secretion of proteases. The gels were also
immobilized with 1 mM of a cell adhesion sequence RGDS to allow for cell attachment
within the network. To induce matrix softening, gels were treated with 25µM SrtA
and 12mM Glycinamide. Not surprisingly, gels crosslinked with SrtA-sensitive G pep-
tide led to higher degree of hMSC spreading (Figure 4.9a). Image analysis results
show that the cells cultured in the softened hydrogels were significantly more elon-
gated and less circular (quantified as 4pi Area
Perimeter2
), Figure 4.9b). Cells in the softened
hydrogels also spread more as quantified by the average area per cell (Figure 4.9c).
Collectively, these results have demonstrated the applicability of the SrtA-mediated
transpeptidation as an on-demand, tunable, and cytocompatible method for softening
cell-laden hydrogels.
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Fig. 4.9: Effect of SrtA-mediated softening on hMSC morphology. (a)
Representative z-stack images of live and dead stained hMSCs (on days 1,7 and 14)
and F-actin/DAPI staining (on day 14) encapsulated within 3.5% wt PEG-50%
MMP-50% KCLPRT(A/G)CK-1mM CRGDS (R=1) hydrogels treated with 25µM
SrtA and 12mM glycinamide for 4 hours on day 7. (b) Circularity and (c) average
cell area of encapsulated hMSCs quantified in ImageJ from day 14 F-actin/DAPI
staining. (n=85 cells for the stiff condition, n=142 cells for the softened condition).
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4.4 SrtA-Mediated Ligand Exchange
In addition to controlled softening of cell-laden hydrogels, SrtA-mediated transpep-
tidation was also explored for dynamically introducing and removing bioactive motifs
on demand. To achieve this, hydrogels were polymerized using thiol-norbornene pho-
toclick chemistry. Pendant peptide ligands were immobilization into the network
during gel crosslinking. To render the pendant ligand sensitive to SrtA-mediated
transpeptidation, the sequence LPRTG was inserted before the actual bioactive mo-
tif. Through incubation with SrtA and an N-terminal glycine containing substrate
(e.g., GGGRGDS, Glycinamide, etc.), the initially immobilized ligand can be removed
or exchanged with another desired bioactive group (Figure 4.10).
Fig. 4.10: Schematic of SrtA-mediated ligand exchange system. Crosslinking and
immobilization of pendant ligand initiated by photoinitiator LAP and UV (365nm)
light exposure. Introduction of specific ligands into the system is achieved through
treatment with the N-terminal Glycine containing ligand and SrtA.
Exchange/removal of said ligand can be achieved through treatment with another
oligoglycine substrate and SrtA.
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4.4.1 Effects of Ligand Exchange on Hydrogel Stiffness
We first sought to understand the effects of dynamic ligand exchange on the me-
chanical properties of the treated hydrogels. SrtA-sensitive pendant ligands (i.e., 0, 1,
or 2 mM CLPRTGRGDS) were immobilized into hydrogels crosslinked by PEG8NB
macromer and DTT crosslinker. Hydrogels immobilized with different concentrations
of the peptide ligand did not yield significantly different initial moduli (Figure 4.11a).
This makes sense, as the pendant ligand did not contribute to crosslinking density of
the network. After treating the peptide-immobilized hydrogels with 25µM SrtA and
12mM GGGGC for 4 hours, moduli of hydrogels were measured again and no sig-
nificant difference was found (Figure 4.11a), suggesting that the removal of pendant
peptide ligands can be achieved independent of network crosslinking density. To con-
firm that GRGDS was displaced by GGGGC, the treated hydrogels were first washed
to remove residual SrtA (which contains a single reactive cysteine residue) and any
soluble unreacted GGGGC. The washed gels were then placed in a solution containing
excess Ellmans reagent to label free cysteine residues that were immobilized within the
hydrogel network after the SrtA-mediated ligand exchange. Gels which were formed
with SrtA sensitive pendant groups (i.e., 1 mM or 2 mM CLPRTGRGDS) produced
significant yellow tints after SrtA and GGGGC treatment associated with reacted Ell-
mans reagent compared to gels which had no SrtA-sensitive pendant groups (Figure
4.11b).
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Fig. 4.11: (a) 3% wt PEG8NB-5mMKCLPRTACK-Varied CLPRTGRGDS (25µM
SrtA, 12mM GGGGC, 4-hour treatment time). (b) Gels treated with Ellmans
Reagent.
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4.4.2 Quantification of Ligand Exchange
The efficiency of peptide ligand exchange was evaluated next using different SrtA
concentrations. For this purpose, PEG8NB hydrogels were created with PEG4SH
crosslinker and a SrtA-sensitive pendant peptide (CLPRTGYK). The removal of GYK
from the immobilized CLPRTGYK was quantified by detecting the concentration of
liberated tyrosine within solution using a modified MBTH assay. Briefly, a small
aliquot containing the released GYK peptide was mixed with excess MBTH and
1 kU/mL tyrosinase. Tyrosinase catalyzes the oxidation of tyrosine residues into
dihydroxyphenylalanine (DOPA), which is further oxidized into DOPAquinone and
react with MBTH to form an MBTH-Quinone adduct. The latter had a detectable
absorbance at 460nm (Figure 4.12).
Fig. 4.12: Schematic for quantification of GYK removal via SrtA-mediated
transpeptidation.
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Experimentally, hydrogels were first washed to elute free CLPRTGYK that was
not immobilized in the PEG-peptide hydrogel network. Next, this solution was col-
lected to calculate the relative immobilization efficiency of the peptide within the
hydrogels (82.2±3.4% immobilized) and for use in normalization of release data. Af-
ter treatment of the gels for 4 hours with varied concentrations of SrtA and 24mM
glycinamide (4-fold excess with respect to ligand concentration), the solutions were
collected and soluble GYK measured to calculate percent released. We found that
after 4 hours only 20% of GYK ligand was cleaved at 25µM SrtA. This is much lower
than we would have expected based on softening completing after about 4 hours of
treatment with 25µM SrtA. The high efficiency of softening is likely due to an increase
in distance of the cleaved -LPRTGn and G- groups from each other within the soft-
ening network. If the oligoglycine substrate is not in close proximity to the thioester
intermediate, it would be less likely to react with the intermediate. As the pendant
ligand, GYK in this experiment, was cleaved from the network it remained in the so-
lution and was free to diffuse throughout the matrix. It could react with the thioester
intermediate, leading to the re-addition of the peptide. As the concentration of SrtA
was increased, significantly more ligand was removed (Figure 4.13a). This was likely
due to the increase in potential ligand exchange events as each SrtA enzyme can only
interact with local pendants ligand groups. We next wanted to look at the possibility
of extending treatment time as an alternative to using a higher concentration of SrtA.
When the treatment time of gels was increased (25µM SrtA, 24mM glycinamide for
4, 8, or 24 hours), there was a significant and time-dependent increase in the total
ligand removal (Figure 4.13b). Increasing enzyme incubation time would allow for the
enzyme to interact with more pendant ligands within the gels. As the cytocompat-
ibility of the SrtA transpeptidation was previously demonstrated in the softening of
hMSC-laden hydrogels, the focus turned towards investigating SrtA-mediated ligand
exchange within cell culture.
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Fig. 4.13: Hydrogels were created with 4.5% wt PEG8NB-2.5mM PEG4SH-6mM
CLPRTGYK. (a) Effect of SrtA concentration on ligand removal. Gels were treated
with 24mM glycinamide and varied concentrations of SrtA for 4 hours. (b) Effect of
treatment time with SrtA and glycinamide on ligand removal. Gels were treated
with 24mM glycinamide and 25µM SrtA for varied treatment times. (n=3).
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4.4.3 SrtA-Mediated RGDS Removal in 2D 3T3 Cell Culture
We next sought to test the ligand exchange system in cell culture. To do this we
seeded 3T3 fibroblasts on top of hydrogels containing SrtA-sensitive RGDS pendant
peptide (i.e., CLPRTGRGDS). The cells were allowed to grow for 1 day prior to
treatment with one of the 4 conditions (i.e., normal media, glycinamide, SrtA, or
SrtA and glycinamide). Live cell imaging was performed over 48 hours (with 2-hour
intervals between images). From the brightfield images, it can be seen that cells spread
less when treated with SrtA and glycinamide when compared to cell treated with one
of the two or in control media (Figure 4.14a). This suggests that the integrin-ligand
RGDS was removed from the hydrogel surface after SrtA treatment. Quantification
results of average cell cluster area (Figure 4.14b) and average cell cluster aspect ratios
(Figure 4.14c) using ImageJ software show the same trend. Cells treated with either
glycinamide or SrtA alone also had a lower average cell cluster area and aspect ratio in
comparison to the control group. As the SrtA reaction is able to facilitate hydrolysis,
it is reasonable that some of the pendant RGDS motifs would be hydrolyzed over the
48 hours of SrtA incubation. Interestingly, the addition of glycinamide into the cell-
culture media led to a yellow tinted solution. As the media contains phenol red, a pH
indicator, this would signal that the glycinamide-media solution is not at physiological
pH. This would likely affect natural cell processes such as spreading and survival. In
comparison, these two conditions were more confluent and contained more spreading
than the cells treated with SrtA and glycinamide together. This would support that
the transpeptidation reaction led to increased RGDS removal in this condition.
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Fig. 4.14: SrtA-mediated removal of pendant RGDS motifs from 3T3 cells cultured
on top of hydrogels. (a) Representative 12 hour brightfield images of 3T3 cells
cultured on gels containing SrtA-sensitive RGDS peptide and treated with various
conditions (scale bar = 200µm). (b) Quantification of average cell cluster area at
12-hour intervals from the four treatment conditions. (c) Quantification of average
cell cluster aspect ratios at 12-hour intervals.
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4.4.4 SrtA-Mediated RGDS Removal in 3D 3T3 Cell Culture
We next investigated whether the SrtA-mediated ligand exchange system could
be used to affect adhesion of cells encapsulated within hydrogels. To achieve this,
3T3 fibroblasts were encapsulated in PEG-peptide hydrogels with immobilized SrtA-
sensitive pendant RGDS ligand (i.e., CLPRTGRGDS). Gels were either treated with
25µM SrtA and 12mM glycinamide for 24 hours directly after encapsulation or were
not treated. Cells encapsulated within gels that were treated with SrtA showed lower
degree of spreading compared to their non-treated counterparts (Figure 4.15). These
results suggested that SrtA-treatment led to removal of RGD ligands from the cell-
laden hydrogels and in turn reduced spreading.
Fig. 4.15: Effect of SrtA-mediated GRGDS removal on 3T3 cell morphology.
Representative z-stack images of live and dead stained (on days 1,7 and 14) and
F-actin/DAPI stained (on day 14) 3T3 cells encapsulated within 2.5% wt
PEG-MMP-1mM CLPRTGRGDS (R=1). Removal gels were treated with 25µM
SrtA and 12mM glycinamide for 24 hours on day 0.
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CHAPTER 5. SUMMARY AND RECOMMENDATIONS
5.1 Summary
In summary, a tunable hydrogel system capable of being softened enzymatically
was developed. Softening was achieved using relatively low concentrations of SrtA.
4 hours of enzyme treatment was sufficient to reach a terminal degree of softening.
Compared to non-dynamic hydrogels, hMSCs responded to softening of the matrix
by spreading more. The use of SrtA as a means of introducing new ligands into the
system was also investigated. Ligand removal from hydrogels treated with varied
concentrations of SrtA and for varied treatment times was also characterized. Specif-
ically, increasing the concentration of SrtA and treatment time both led to increased
degrees of ligand exchange. In 2D culture, it was demonstrated that the removal
of cell adhesion peptide (RGDS) via SrtA-mediated transpeptidation, decreased the
spreading of 3T3 fibroblasts. On the other hand, a similar trend was observed for
3T3 fibroblasts encapsulated within hydrogels that were treated with SrtA to remove
RGDS ligands. After RGDS removal, encapsulated cells exhibited less spreading when
compared to the cells cultured within gels without RGDS removal.
5.2 Recommendations
Much of the work done in this thesis was focused on the use of inert PEG-based
polymers with the inclusion of bioactive motifs (RGDS, GPQGIWGQ, etc.). Due to
the specificity of SrtA transpeptidation, this softening and ligand exchange system can
be adapted for use in natural material-based hydrogels such as gelatin and hyaluronic
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acid. Natural materials are advantageous to synthetic polymers such as PEG, in that
they often contain motifs for cellular adhesion and degradation, and they are derived
from natural tissue. As the ligand exchange system has been characterized well out-
side of cell culture, further work into its utilization, such as demonstrating repeatedly
exchanged motifs or growth factors may be desirable. As seen in wound healing,
there is often dynamic changes in ECM proteins such as collagen. The reduction in
collagen leads to a changes in local bioactive motifs and releases entrapped growth
factors. To better recapitulate the dynamic environments seen naturally within the
body, it is ideal to be able to mimic those changes in culture.
This work can also be furthered through the creation of a diffusion-kinetics model.
A model would be applicable for predicting the completion of both the softening and
ligand exchange systems. This would be useful for designing treatment conditions for
future experiments.
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